Traditional methods for developing new proteins — critical in biotechnology, pharmaceuticals and industrial catalysis — are notoriously slow. This project utilizes ultra-High-Throughput Screening (uHTS) to identify variants with desired functions, crucial for the rapidly expanding $24 billion global HTS market.
